ALBERT BOURLA - 15 Mar 2023 Form 4 Insider Report for PFIZER INC (PFE)

Role
Chairman & CEO, Director
Signature
Susan E. Grant, by power of atty., for Albert Bourla
Issuer symbol
PFE
Transactions as of
15 Mar 2023
Net transactions value
+$3,053,775
Form type
4
Filing time
17 Mar 2023, 19:19:20 UTC
Previous filing
28 Feb 2023
Next filing
03 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Phantom Stock Units SSP Award $53,774 +1,335 +1.3% $40.28 100,977 15 Mar 2023 Common Stock 1,335 Direct F1, F2
transaction PFE Phantom Stock Units SSP Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities $3,000,001 +74,813 +74% $40.10 175,790 17 Mar 2023 Common Stock 74,813 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each unit represents one phantom share of common stock.
F2 These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
F3 This transaction constitutes an intra-plan transfer to acquire Pfizer stock units in the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan.